Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
The mechanism of action of Retatrutide involves interaction with three hormones: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic peptide), and glucagon
"Structure of the integral membrane domain of the GLP1 receptor"
Retatrutide for Metabolic Research Retatrutide for Metabolic Dysfunction-Associated Research Retatrutide is currently being investigated for research involving: Obesity Metabolic dysfunction-associated steatotic liver disease Glycemic control Endocrine signaling Weight management Multiple metabolic pathways Triple-Hormone-Receptor Agonist Retatrutide for Obesity Research involving receptor agonist retatrutide for metabolic dysfunction-associated conditions has gained significant interest because the peptide influences: GLP-1 receptor pathways GIP receptor signaling Glucagon receptor activity Energy expenditure Appetite regulation Several phase 2 trial studies involving obesity and glycemic control demonstrated promising metabolic outcomes
The comparison between mazdutide and retatrutide provides context on how different multi-agonist approaches compare in terms of side effect profiles
US$ 25.17
US$ 28.40
US$ 26.24
US$ 20.78
US$ 24.61
US$ 23.62
